Clinical Trial Update: Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer

View source ↗

Summary

A clinical trial evaluating metabolomics as a predictor of treatment response and toxicities in rectal cancer. Sponsored by Chang Gung Memorial Hospital, the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Rectal Neoplasm Malignant | Status: RECRUITING